QQ客服 官方微博 反馈留言

	Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 Study: AURORA study
	Li, X.; Xu, G.; Wang, Y.; Xu, X.; Liu, X.; Tang, S.; Zhang, F.; Zhang, J.; Tang, L.; Wu, Q.
刊名	Ophthalmology
	2014
卷号	Vol.121 No.9页码:1740-1747
关键词	Abbreviations and Acronyms adverse event AE age-related macular degeneration AMD Assess the safety and efficacy of KH902 in patients with sUbfoveal choroidal neovasculaRization secOndary to age-Related mAcular degeneration AURORA BCVA best-corrected visual acuity central retinal thickness choroidal neovascularization CLEAR-IT CLinical Evaluation of Anti-angiogenesis in the Retina Intravitreal Trial CNV CRT Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Agerelated Macular Degeneration (AMD) EXCITE FA fluorescein angiography FP fundus photography ICGA indocyanine green angiography monthly OCT optical coherence tomography PRN pro re nata Q1M SAE severe adverse event vascular endothelial growth factor VEGF
ISSN号	0161-6420
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1817782
专题	四川大学
作者单位	1.j Department of Clinical Research, Chengdu Kanghong Biotechnology, Inc., Chengdu, China 2.g Department of Ophthalmology, Peking Tongren Hospital, Beijing, China 3.Department of Ophthalmology, Shanghai First People's Hospital, Shanghai, China 4.Department of Ophthalmology, Xijing Hospital of the Fourth Military Medical University, Xian, Shanxi, China 5.a Department of Ophthalmology, Peking University People's Hospital, Beijing, China 6.Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China 7.f Department of Ophthalmology, Zhongshan Ophthalmic Center, Sun-Yat University, Guangzhou, Guangdong, China 8.i Department of Ophthalmology, Second Affiliated Hospital, Xiangya Medical College, Changsha, Hunan, China 9.Department of Ophthalmology, Optometry and Ophthalmology Hospital of Wenzhou Medical College, Wenzhou, Fujian, China 10.h Department of Ophthalmology, Sichuan University West China Hospital, Chengdu, Sichuan, China
推荐引用方式 GB/T 7714	Li, X.,Xu, G.,Wang, Y.,et al. Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 Study: AURORA study[J]. Ophthalmology,2014,Vol.121 No.9:1740-1747.
APA	Li, X..,Xu, G..,Wang, Y..,Xu, X..,Liu, X..,...&Ke, X..(2014).Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 Study: AURORA study.Ophthalmology,Vol.121 No.9,1740-1747.
MLA	Li, X.,et al."Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 Study: AURORA study".Ophthalmology Vol.121 No.9(2014):1740-1747.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。